Bolt Biotherapeutics Inc (BOLT)

$4.78 +0.08 (1.70%)
Market Cap 9.03M
Revenue (ttm) 7.70M
Net Income (ttm) -33.38M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -433.51%
Debt to Equity Ratio 0.00
Volume 21,000
Avg Vol 22,280
Day's Range N/A - N/A
Shares Out 1.92M
Stochastic %K 41%
Beta 1.10
Analysts Sell
Price Target $6.00

Company Profile

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company's pipeline products include BDC-4182, a next-generation Boltbody ISAC that targets the tumor-associated antigen claudin 18.2 for the treatment of gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types; BDC-3042, a dectin-2 agonist antibody program for the treatment of non-small cell lung cancer, melanoma, and other solid tumor...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 665 9295
Address:
900 Chesapeake Drive, Redwood City, United States
Golibajje
Golibajje May. 8 at 2:17 PM
$FCHL Saw this in one of the trader group list as a short recommendation.. missed! Worth considering $BOLT which has major clinical trial results in Q3. Could be 500%+ gains there if the results are positive.. it’s the only in that ISAC space.. no competition!
1 · Reply
BillionerOfKing
BillionerOfKing May. 4 at 8:33 PM
$BOLT Current Stock Price: $4.99
0 · Reply
BuyNow_SellLater
BuyNow_SellLater Apr. 27 at 4:57 PM
$BOLT good day to add here
0 · Reply
SheriffGrover
SheriffGrover Apr. 25 at 10:30 PM
$BOLT https://www.fiercebiotech.com/biotech/pfizer-ends-work-phase-1-stage-immunostimulatory-drug-conjugate-cancer-patients Thoughts ? TIA
0 · Reply
SheriffGrover
SheriffGrover Apr. 25 at 9:39 PM
$BOLT https://www.fiercebiotech.com/biotech/compass-usona-score-fda-national-priority-vouchers-amid-trump-administrations-psychedelic
1 · Reply
SuperGreenToday
SuperGreenToday Apr. 22 at 1:19 AM
$BOLT
0 · Reply
Golibajje
Golibajje Apr. 21 at 2:18 PM
$BOLT Cup and handle formation on an upcoming milestone - Phase 1 results in Q3!! Quietly going up!! Major and only player in ISAC treating cancer, targeting $18 billion market!!! Trading at $9.5m mkt cap with $31 million cash!! $ENVB $CMPS
0 · Reply
Golibajje
Golibajje Apr. 20 at 2:20 PM
$BOLT Another one will move like $ENVB. Cup and handle formation for $BOLT ! Pfizer holding shares in 1.9 million float with mkt cap of $9M!! Cash it self is $31 million!! Only isac player targeting cancer 18.2 claudin in the field.. Phase 1 results in Q3!! Trading almost at lower end.. 1/3.5 of cash!!
0 · Reply
Golibajje
Golibajje Apr. 16 at 4:50 AM
$BOLT Cup and handle formation! Watch out
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 16 at 1:44 AM
$BOLT RSI: 56.59, MACD: 0.0393 Vol: 0.24, MA20: 4.56, MA50: 4.68 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Latest News on BOLT
Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

May 12, 2026, 4:05 PM EDT - 16 hours ago

Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Bolt Biotherapeutics reports Q4 EPS ($3.84), consensus ($5.52)

2026-03-12T20:31:03.000Z - 2 months ago

Bolt Biotherapeutics reports Q4 EPS ($3.84), consensus ($5.52)

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update

Mar 12, 2026, 4:05 PM EDT - 2 months ago

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update

Bolt Biotherapeutics to Participate in Upcoming March Conferences

Feb 24, 2026, 8:00 AM EST - 2 months ago

Bolt Biotherapeutics to Participate in Upcoming March Conferences

Bolt Biotherapeutics reports Q3 EPS ($3.72), consensus ($5.39)

2025-11-12T21:50:29.000Z - 6 months ago

Bolt Biotherapeutics reports Q3 EPS ($3.72), consensus ($5.39)

Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 12, 2025, 4:05 PM EST - 6 months ago

Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Bolt Biotherapeutics assumed with a Buy at H.C. Wainwright

2025-10-20T10:25:50.000Z - 7 months ago

Bolt Biotherapeutics assumed with a Buy at H.C. Wainwright

Bolt Biotherapeutics to reduce workforce by 50%, gives update on BDC-4182 study

2025-10-01T20:10:39.000Z - 7 months ago

Bolt Biotherapeutics to reduce workforce by 50%, gives update on BDC-4182 study

Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027

Oct 1, 2025, 4:05 PM EDT - 7 months ago

Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027

Bolt Biotherapeutics target adjusted to $75 at Lake Street after reverse split

2025-08-15T12:50:22.000Z - 9 months ago

Bolt Biotherapeutics target adjusted to $75 at Lake Street after reverse split

Bolt Biotherapeutics reports Q2 EPS ($4.46), consensus ($6.27)

2025-08-14T20:15:29.000Z - 9 months ago

Bolt Biotherapeutics reports Q2 EPS ($4.46), consensus ($6.27)

Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 14, 2025, 4:05 PM EDT - 9 months ago

Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Bolt Biotherapeutics Inc trading halted, news pending

2025-06-06T23:50:07.000Z - 1 year ago

Bolt Biotherapeutics Inc trading halted, news pending

Bolt Biotherapeutics initiated with a Buy at Lake Street

2025-05-20T12:45:48.000Z - 1 year ago

Bolt Biotherapeutics initiated with a Buy at Lake Street

GMAB

Bolt Biotherapeutics price target lowered to $1 from $1.25 at Stifel

2025-05-13T11:16:52.000Z - 1 year ago

Bolt Biotherapeutics price target lowered to $1 from $1.25 at Stifel

Bolt Biotherapeutics Transcript: Status Update

May 12, 2025, 5:30 PM EDT - 1 year ago

Bolt Biotherapeutics Transcript: Status Update

Bolt Biotherapeutics reports Q1 EPS (29c), consensus (36c)

2025-05-12T20:31:39.000Z - 1 year ago

Bolt Biotherapeutics reports Q1 EPS (29c), consensus (36c)

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 12, 2025, 4:05 PM EDT - 1 year ago

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Biotech Alert: Searches spiking for these stocks today

2025-05-08T16:25:17.000Z - 1 year ago

Biotech Alert: Searches spiking for these stocks today

HRTX IBRX MDXG QURE SLGL SPRC SRPT

Bolt Biotherapeutics to host KOL call on BDC-3042 Phase 1 results

2025-05-08T12:30:14.000Z - 1 year ago

Bolt Biotherapeutics to host KOL call on BDC-3042 Phase 1 results

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates

May 8, 2025, 8:00 AM EDT - 1 year ago

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates

Bolt Biotherapeutics announces results for Boltbody ISACs at AACR meeting

2025-04-30T20:50:38.000Z - 1 year ago

Bolt Biotherapeutics announces results for Boltbody ISACs at AACR meeting

Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025

Apr 30, 2025, 4:05 PM EDT - 1 year ago

Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Apr 25, 2025, 1:00 PM EDT - 1 year ago

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Mar 25, 2025, 4:30 PM EDT - 1 year ago

Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Bolt Biotherapeutics reports Q4 EPS (42c), consensus (35c)

2025-03-25T19:19:39.000Z - 1 year ago

Bolt Biotherapeutics reports Q4 EPS (42c), consensus (35c)

Bolt Biotherapeutics price target lowered to $1.25 from $1.50 at Stifel

2025-03-25T19:02:15.000Z - 1 year ago

Bolt Biotherapeutics price target lowered to $1.25 from $1.50 at Stifel

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Mar 24, 2025, 4:20 PM EDT - 1 year ago

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Bolt Biotherapeutics provides update on co-development collaboration with Toray

2025-02-11T21:45:40.000Z - 1 year ago

Bolt Biotherapeutics provides update on co-development collaboration with Toray

Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.

Feb 11, 2025, 4:05 PM EST - 1 year ago

Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.

Bolt Biotherapeutics reports Q3 EPS (40c), consensus (35c)

2024-11-12T21:40:03.000Z - 1 year ago

Bolt Biotherapeutics reports Q3 EPS (40c), consensus (35c)

Bolt Biotherapeutics presents updated preclinical data for BDC-4182

2024-11-07T15:10:49.000Z - 1 year ago

Bolt Biotherapeutics presents updated preclinical data for BDC-4182

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

Nov 7, 2024, 10:00 AM EST - 1 year ago

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

Bolt Biotherapeutics Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 9, 2024, 7:00 AM EDT - 1 year ago

Bolt Biotherapeutics Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Bolt Biotherapeutics Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Sep 6, 2024, 7:00 AM EDT - 1 year ago

Bolt Biotherapeutics Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Bolt Biotherapeutics names Brian O’Callaghan chairman

2024-09-04T20:30:32.000Z - 1 year ago

Bolt Biotherapeutics names Brian O’Callaghan chairman

Bolt Biotherapeutics Announces Changes to its Board of Directors

Sep 4, 2024, 4:05 PM EDT - 1 year ago

Bolt Biotherapeutics Announces Changes to its Board of Directors

Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 13, 2024, 4:05 PM EDT - 1 year ago

Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

BOLT Investors Have Opportunity to Actively Participate Bolt Biotherapeutics, Inc.

Jul 26, 2024, 10:00 AM EDT - 1 year ago

BOLT Investors Have Opportunity to Actively Participate Bolt Biotherapeutics, Inc.

BOLT Investors Have Opportunity to Lead Bolt Biotherapeutics, Inc.

Jul 25, 2024, 10:00 AM EDT - 1 year ago

BOLT Investors Have Opportunity to Lead Bolt Biotherapeutics, Inc.

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Bolt Biotherapeutics, Inc. (BOLT)

Jul 3, 2024, 4:47 PM EDT - 2 years ago

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Bolt Biotherapeutics, Inc. (BOLT)

Bolt Biotherapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Jun 24, 2024, 3:36 PM EDT - 2 years ago

Bolt Biotherapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Golibajje
Golibajje May. 8 at 2:17 PM
$FCHL Saw this in one of the trader group list as a short recommendation.. missed! Worth considering $BOLT which has major clinical trial results in Q3. Could be 500%+ gains there if the results are positive.. it’s the only in that ISAC space.. no competition!
1 · Reply
BillionerOfKing
BillionerOfKing May. 4 at 8:33 PM
$BOLT Current Stock Price: $4.99
0 · Reply
BuyNow_SellLater
BuyNow_SellLater Apr. 27 at 4:57 PM
$BOLT good day to add here
0 · Reply
SheriffGrover
SheriffGrover Apr. 25 at 10:30 PM
$BOLT https://www.fiercebiotech.com/biotech/pfizer-ends-work-phase-1-stage-immunostimulatory-drug-conjugate-cancer-patients Thoughts ? TIA
0 · Reply
SheriffGrover
SheriffGrover Apr. 25 at 9:39 PM
$BOLT https://www.fiercebiotech.com/biotech/compass-usona-score-fda-national-priority-vouchers-amid-trump-administrations-psychedelic
1 · Reply
SuperGreenToday
SuperGreenToday Apr. 22 at 1:19 AM
$BOLT
0 · Reply
Golibajje
Golibajje Apr. 21 at 2:18 PM
$BOLT Cup and handle formation on an upcoming milestone - Phase 1 results in Q3!! Quietly going up!! Major and only player in ISAC treating cancer, targeting $18 billion market!!! Trading at $9.5m mkt cap with $31 million cash!! $ENVB $CMPS
0 · Reply
Golibajje
Golibajje Apr. 20 at 2:20 PM
$BOLT Another one will move like $ENVB. Cup and handle formation for $BOLT ! Pfizer holding shares in 1.9 million float with mkt cap of $9M!! Cash it self is $31 million!! Only isac player targeting cancer 18.2 claudin in the field.. Phase 1 results in Q3!! Trading almost at lower end.. 1/3.5 of cash!!
0 · Reply
Golibajje
Golibajje Apr. 16 at 4:50 AM
$BOLT Cup and handle formation! Watch out
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 16 at 1:44 AM
$BOLT RSI: 56.59, MACD: 0.0393 Vol: 0.24, MA20: 4.56, MA50: 4.68 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Golibajje
Golibajje Apr. 15 at 10:57 PM
$BOLD Along with this $BOLT is another lottery ticket in the making! It is trading nearly 1/4th of cash (low float with 1.9m shares.. $9M mkt cap vs $31M cash).. they have phase 1 results in Q3.. disruptive treatment in BILLION $$ mkt! Could go 500%+ if the results are positive! $ZNTL $ALMS
1 · Reply
23krash
23krash Apr. 10 at 8:04 PM
$BOLT
0 · Reply
skyrockets_Inc
skyrockets_Inc Apr. 10 at 7:40 PM
$BOLT Patience here shall be rewarded imo. Seems prime for another run up to $7
0 · Reply
HartFoundation
HartFoundation Apr. 8 at 2:26 PM
$BOLT let's go!
0 · Reply
MetricWhale
MetricWhale Apr. 7 at 12:10 PM
$BOLT looks like a slow melter
0 · Reply
skyrockets_Inc
skyrockets_Inc Apr. 6 at 7:56 PM
$BOLT Is it finally time?
0 · Reply
MetricWhale
MetricWhale Apr. 3 at 3:51 PM
$BOLT low-key sleeper setup worth watching.
0 · Reply
skyrockets_Inc
skyrockets_Inc Apr. 1 at 3:08 PM
$BOLT bought more today here w/ my $CYCN winnings
1 · Reply
SheriffGrover
SheriffGrover Mar. 26 at 4:25 PM
$BOLT vol. 800 .... Calm before the storm ;O) ???
0 · Reply
MetricWhale
MetricWhale Mar. 25 at 7:19 PM
$BOLT starting to curl. Can fly with volume
0 · Reply
MindfulMonkey
MindfulMonkey Mar. 25 at 10:36 AM
$BOLT $ALZN is gonna pop by the end of the week, i'm bringing all my profits to BOLT
0 · Reply